Rampart Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-7,761
Closed -$490K 148
2020
Q3
$490K Sell
7,761
-17,910
-70% -$1.24M 0.31% 79
2020
Q2
$1.98M Buy
25,671
+6,984
+37% +$535K 0.33% 85
2020
Q1
$1.4M Buy
18,687
+3,883
+26% +$268K 0.66% 28
2019
Q4
$962K Buy
14,804
+398
+3% +$25.9K 0.12% 224
2019
Q3
$913K Sell
14,406
-392
-3% -$25.6K 0.11% 230
2019
Q2
$1M Sell
14,798
-1,105
-7% -$72.7K 0.12% 222
2019
Q1
$1.03M Buy
15,903
+2,007
+14% +$133K 0.12% 226
2018
Q4
$869K Sell
13,896
-8,360
-38% -$584K 0.24% 108
2018
Q3
$1.12M Sell
22,256
-2,379
-10% -$180K 0.49% 51
2018
Q2
$1.75M Sell
24,635
-10,425
-30% -$736K 0.17% 165
2018
Q1
$2.64M Buy
35,060
+19,044
+119% +$1.51M 0.25% 120
2017
Q4
$1.15M Sell
16,016
-1,850
-10% -$140K 0.44% 54
2017
Q3
$1.45M Buy
17,866
+851
+5% +$65.1K 0.49% 45
2017
Q2
$1.2M Buy
17,015
+13,395
+370% +$891K 0.43% 46
2017
Q1
$246K Buy
+3,620
New +$255K 0.09% 56

Other funds holding GILD

Rampart Investment Management's GILD Position: Q4 2020 in Review

Rampart Investment Management sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 7,761 shares — an estimated $490K sold.

Rampart Investment Management first reported a position in GILD in Q1 2017 and held it in 15 quarters. The position peaked at $2.64M in Q1 2018. 1,564 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Rampart Investment Management reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • Rampart Investment Management sold 7,761 Gilead Sciences shares in Q4 2020, an estimated $490K.
  • Rampart Investment Management first reported a position in Gilead Sciences in Q1 2017 and held it in 15 quarters.
  • Rampart Investment Management's Gilead Sciences position peaked at $2.64M in Q1 2018.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Rampart Investment Management's 13F filing for Q4 2020.